Mediator release in cerebrospinal fluid of human immunodeficiency virus-positive patients with central nervous system involvement

[1]  J. Sidtis,et al.  AIDS Dementia Complex and HIV‐1 Infection: A View From the Clinic , 1991, Brain pathology.

[2]  M. McGrath,et al.  Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains. , 1991, The Journal of clinical investigation.

[3]  A. Lazzarin,et al.  Elevated alpha–tumor necrosis factor levels in spinal fluid from HIV‐1–infected patients with central nervous system involvement , 1991, Annals of neurology.

[4]  D. Giulian,et al.  Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1 , 1990, Science.

[5]  R. Price,et al.  Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection , 1990, Annals of neurology.

[6]  C. Kufta,et al.  Specific tropism of HIV-1 for microglial cells in primary human brain cultures. , 1990, Science.

[7]  S. Lipton,et al.  HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. , 1990, Science.

[8]  A. Lazzarin,et al.  Enhanced basophil releasability in subjects infected with human immunodeficiency virus. , 1990, Clinical immunology and immunopathology.

[9]  K. Frei,et al.  Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid , 1989, Journal of Neuroimmunology.

[10]  R. Price,et al.  Cerebrospinal fluid ß2 microglobulin in patients infected with human immunodeficiency virus , 1989, Neurology.

[11]  E. Werner,et al.  Neopterin concentrations in cerebrospinal fluid and serum of individuals infected with HIV-1. , 1989, AIDS.

[12]  I. Elovaara,et al.  CSF and serum β‐2‐microglobulin in HIV infection related to neurological dysfunction , 1989, Acta neurologica Scandinavica.

[13]  R. Price,et al.  The AIDS dementia complex. , 1988, The Journal of infectious diseases.

[14]  R. Rodriguez y Baena,et al.  CSF leukotriene C4 following subarachnoid hemorrhage. , 1988, Journal of neurosurgery.

[15]  J. Berger.  THE NEUROLOGICAL COMPLICATIONS OF HIV INFECTION , 1988, Acta neurologica Scandinavica. Supplementum.

[16]  E. Werner,et al.  Neopterin as a marker for activated cell-mediated immunity: application in HIV infection. , 1988, Immunology today.

[17]  J. Sidtis,et al.  The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. , 1988, Science.

[18]  D. Fuchs,et al.  Neopterin levels correlating with the Walter Reed staging classification in human immunodeficiency virus (HIV) infection. , 1987, Annals of internal medicine.

[19]  M. Arning,et al.  NEOPTERIN AND β2-MICROGLOBULIN AS MARKERS FOR AIDS , 1987, The Lancet.

[20]  A. Lazzarin,et al.  Impairment of polymorphonuclear leucocyte function in patients with acquired immunodeficiency syndrome and with lymphadenopathy syndrome. , 1986, Clinical and experimental immunology.

[21]  B. Navia,et al.  The AIDS dementia complex: I. Clinical features , 1986, Annals of neurology.

[22]  B. Navia,et al.  Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome. , 1985, The New England journal of medicine.

[23]  R. Egan,et al.  Measuring leukotrienes of slow reacting substance of anaphylaxis: development of a specific radioimmunoassay. , 1983, Journal of immunology.

[24]  R. Siraganian.  An automated continuous-flow system for the extraction and fluorometric analysis of histamine. , 1974, Analytical biochemistry.

[25]  R. Redfield,et al.  Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. , 1986, MMWR. Morbidity and mortality weekly report.

[26]  J. Maclouf,et al.  Development of a radioimmunoassay for prostaglandin D2 using an antiserum against 11-methoxime prostaglandin D2. , 1986, Prostaglandins.